METASTATIC SOLID TUMORS
Clinical trials for METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to boost power of cancer immunotherapy
Disease control OngoingThis study is testing if adding an experimental drug called NP137 to standard immunotherapy helps patients with advanced solid tumors. It focuses on people whose cancer has stopped responding well to their current immunotherapy. The goal is to see if the combination can better co…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New cancer drug enters human testing for Tough-to-Treat tumors
Disease control OngoingThis early-stage study is testing a new drug called INCB177054, given alone or with an immunotherapy drug, in people with advanced solid tumors that have spread or cannot be cured by surgery. The main goals are to find a safe dose and see if the treatment can shrink tumors. It is…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for tough cancers: first human test of targeted drug begins
Disease control OngoingThis is an early-stage study to test a new oral drug called TPX-0022 (elzovantinib) in adults with advanced or spreading cancers that have specific changes in a gene called MET. The main goals are to find a safe dose, see how the body processes the drug, and get a first look at w…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Turning Point Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC